Erratum: Kardiovaskuläre Risiken der Therapie mit Zyklooxygenasehemmern (NSAR): Biomarker als Risikoindikatoren? (Aktuelle Rheumatologie (2013) DOI: 10.1055/s-0032-1301928)

Research output: Contribution to specialist publication › Corrections (errata and retractions) › peer-review

Contributors

  • K. Brune - , Friedrich-Alexander University Erlangen-Nürnberg (Author)
  • F. Ren - , Harvard University (Author)
  • C. T. Ruff - , Harvard University (Author)
  • B. Renner - , Friedrich-Alexander University Erlangen-Nürnberg (Author)
Translated title of the contribution
Erratum
Cardiovascular risks of cyclooxygenase inhibitors (NSAIDs): Biomarkers for risk assessment? (Aktuelle Rheumatologie (2013) DOI: 10.1055/s-0032-1301928)

Details

Original languageGerman
Pagese1
Volume38
Issue number1
JournalAktuelle Rheumatologie
Publication statusPublished - 2013
Peer-reviewedYes
Externally publishedYes
No renderer: customAssociatesEventsRenderPortal,dk.atira.pure.api.shared.model.researchoutput.ContributionToPeriodical

Keywords

ASJC Scopus subject areas